|
ZNF470 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.887390E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.724200E-02 |
| Normal-vs-Stage2 |
6.535800E-02 |
| Normal-vs-Stage3 |
7.743200E-01 |
| Normal-vs-Stage4 |
9.396200E-01 |
| Stage1-vs-Stage2 |
4.036600E-01 |
| Stage1-vs-Stage3 |
9.451500E-02 |
| Stage1-vs-Stage4 |
1.014780E-01 |
| Stage2-vs-Stage3 |
6.222000E-02 |
| Stage2-vs-Stage4 |
5.963700E-02 |
| Stage3-vs-Stage4 |
7.189600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.699350E-01 |
| Normal-vs-AfricanAmerican |
4.939000E-01 |
| Normal-vs-Asian |
8.399700E-02 |
| Caucasian-vs-AfricanAmerican |
9.361200E-01 |
| Caucasian-vs-Asian |
5.502000E-01 |
| AfricanAmerican-vs-Asian |
6.859000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.897960E-01 |
| Normal-vs-Female |
1.462240E-01 |
| Male-vs-Female |
8.713400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.632100E-02 |
| Normal-vs-Age(41-60Yrs) |
2.340000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.547400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.113200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.112600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.582760E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.593400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.896000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.189400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.629600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.70869999999557E-05 |
| Classical-VS-Follicular |
2.968400E-02 |
| Classical-VS-Other |
4.067200E-01 |
| Classical-VS-Normal |
2.766400E-02 |
| Tall-VS-Follicular |
1.006240E-01 |
| Tall-VS-Other |
5.770200E-01 |
| Tall-VS-Normal |
1.955170E-01 |
| Follicular-VS-Other |
9.402200E-01 |
| Follicular-VS-Normal |
7.371400E-01 |
| Other-VS-Normal |
9.410400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.009800E-02 |
| Normal-vs-N1 |
6.714400E-01 |
| N0-vs-N1 |
2.326200E-01 |
|
|
